[Diabetes and vascular diabetic disease]

Area of Science:

• Cardiovascular Medicine
• Endocrinology
• Pathophysiology

Context:

• Growing prevalence of type 2 diabetes mellitus globally.
• Vascular disease as a primary cause of morbidity and mortality in diabetic patients.
• Accelerated atherosclerosis accounts for significant mortality and hospitalizations.

Purpose:

• To investigate the pathophysiology of diabetic vascular disease.
• To examine the contribution of inflammation, adipose tissue, and metabolic abnormalities (AGEs, ADMA) to endothelial dysfunction.
• To review current treatment strategies for diabetic vascular disease.

Summary:

• Diabetic vascular disease is characterized by accelerated atherosclerosis, leading to increased ischemic heart disease risk, especially in females.
• Key pathophysiological factors include inflammation, adipose tissue dysfunction, and metabolic abnormalities like advanced glycation end-products (AGEs) and asymmetric dimethylarginine (ADMA).
• These factors contribute to endothelial dysfunction, a central mechanism in the development of vascular complications.

Impact:

• Highlights the critical need for understanding diabetic vascular disease mechanisms.
• Informs the development of targeted therapies to mitigate cardiovascular risk in diabetes.
• Emphasizes the importance of managing inflammation and metabolic factors to prevent vascular complications.